Treatment

CURATED BY: Aaron Zalewski,
MSN, PMHNP-BC
This case report presents a 25-year-old female with tardive dyskinesia and tardive dystonia, which were refractory to valbenazine treatment....

Understanding Drug-Induced Movement Disorders: Risks of Antipsychotics and Anticholinergics

Antipsychotic medications are widely used for psychiatric conditions, but they are associated with significant side effects, including drug-induced movement disorders...
CURATED BY:
Aaron Zalewski,
MSN, PMHNP-BC

Deep Brain Stimulation and Treatment for Severe Tardive Dyskinesia

Tardive dyskinesia (TD) is typically caused by long-term use of dopamine receptor antagonists, especially neuroleptics, and can develop after months...
CURATED BY:
Jon Falletta,
PA-C, CAQ-Psych

Advances in Tardive Dyskinesia Treatment: VMAT2 Inhibitors and the Importance of Early Diagnosis

Recent advances have introduced treatment options, including VMAT2 inhibitors, for patients with tardive dyskinesia (TD), which help suppress symptoms, though...
CURATED BY:
Jon Falletta,
PA-C, CAQ-Psych

Electroconvulsive Therapy: A Promising Alternative for Movement Disorders

Electroconvulsive therapy (ECT), traditionally used for psychiatric disorders, is increasingly recognized for its efficacy in managing movement disorders, even without...
CURATED BY:
Angela C. Combs,
MN, ARNP, PMHNP-BC

Understanding Extrapyramidal System Dysfunction: Causes, Symptoms, and Advances in Treatment

The extrapyramidal system, a complex neural network that coordinates involuntary movements and postural adjustments, plays a vital role in maintaining...
CURATED BY:
Angela C. Combs,
MN, ARNP, PMHNP-BC

Deutetrabenazine Proven Effective and Safe for Long-Term Tardive Dyskinesia Management

Tardive dyskinesia (TD), often associated with dopamine receptor antagonist (DRA) use, affects individuals with psychotic or mood disorders. This study...
CURATED BY:
Jeremy Schreiber,
MSN, PMHNP-BC
Share